influenzaassoci
death
children
adult
nation
report
unit
state
case
studi
pediatr
case
report
cdc
influenzaassoci
pediatr
mortal
surveil
system
system
requir
state
public
health
author
report
cdc
influenzaassoci
death
among
person
year
old
occur
within
jurisdict
inform
collect
surveil
system
constitut
primari
phenotyp
inform
use
studi
includ
underli
health
statu
chronic
medic
condit
influenza
vaccin
statu
clinic
cours
featur
result
microbiolog
virolog
test
report
surveil
system
requir
submiss
tissu
sampl
howev
cdc
routin
receiv
tissu
sampl
subset
fatal
pediatr
influenza
case
diagnost
confirm
case
medic
record
autopsi
report
provid
addit
inform
total
influenzaassoci
death
among
children
year
old
young
adult
year
old
resid
unit
state
report
cdc
influenza
season
case
laboratoryconfirm
influenza
infect
suffici
tissu
specimen
avail
dna
extract
constitut
analyt
dataset
studi
fatal
influenza
case
consid
laboratori
confirm
posit
test
result
influenza
viral
cultur
immunohistochem
analysi
revers
transcript
pcr
rtpcr
document
repres
fatal
pediatr
case
report
cdc
influenza
season
cdc
conduct
surveil
influenzaassoci
pediatr
death
part
emerg
respons
effort
fatal
pediatr
case
identifi
nation
surveil
sinc
pediatr
death
made
nation
notifi
unit
state
fatal
case
influenza
among
young
adult
point
time
among
children
whose
case
report
specimen
receiv
cdc
infecti
diseas
patholog
branch
casebycas
basi
obtain
dna
genotyp
section
block
contain
formalinfix
paraffinembed
tissu
deparaffin
xylen
wash
twice
absolut
ethanol
residu
ethanol
evapor
tissu
digest
overnight
buffer
pkd
proteinas
k
qiagen
valencia
ca
usa
extract
supernat
complet
dna
tissu
kit
magattract
dna
mini
kit
qiagen
dna
elut
final
volum
dna
qualiti
assess
human
rnase
p
realtim
pcr
volum
use
agil
brilliant
ii
qpcr
master
mix
describ
valid
taqman
assay
use
genotyp
snp
protocol
primer
probe
avail
http
realtim
pcr
consist
taqman
univers
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
nmol
assayspecif
primer
nmol
assayspecif
probe
dna
control
extract
blank
templat
control
posit
control
genotyp
use
ng
per
pcr
coriel
institut
medic
research
camden
nj
usa
unknown
sampl
assay
duplic
thermal
cycl
condit
consist
cycl
min
cycl
min
cycl
min
data
collect
anneal
plateau
tnf
examin
promot
snp
unabl
infer
tnf
haplotyp
examin
snp
code
region
exon
promot
region
structur
snp
examin
encod
variant
allel
known
codon
b
codon
c
codon
wildtyp
variant
typic
pool
design
allel
genotyp
aa
refer
wildtyp
homozygot
ao
refer
heterozygot
oo
refer
homozygot
compound
heterozygot
promot
polymorph
posit
hl
variant
xy
variant
encod
variant
mediat
express
casepati
classifi
low
intermedi
high
produc
mbl
basi
structur
promot
variant
refer
truncat
haplotyp
casepati
homozyg
compound
heterozyg
variant
structur
allel
casepati
variant
structur
allel
chromosom
x
variant
categor
low
mbl
produc
casepati
homozyg
wildtyp
structur
allel
categor
high
mbl
produc
except
also
homozyg
x
variant
classifi
intermedi
mbl
produc
basi
evid
possess
xx
promot
genotyp
significantli
downregul
mbl
product
casepati
yao
genotyp
classifi
intermedi
mbl
produc
basi
analys
indic
genotyp
confer
intermedi
level
function
mbl
analys
intermedi
high
produc
combin
group
compar
mbl
lowproduc
preval
genet
variant
among
case
compar
populationbas
preval
estim
genet
variant
age
group
avail
nation
health
nutrit
examin
survey
nhane
iii
cancer
institut
collabor
genom
project
databank
nhane
nation
repres
survey
us
popul
conduct
cdc
nation
center
health
statist
second
phase
nhane
iii
leukocyt
particip
use
creat
dna
bank
maintain
cdc
nation
center
environment
health
contain
specimen
particip
includ
children
knowledg
nhane
dna
bank
current
avail
sourc
nation
repres
preval
estim
genet
variant
among
us
resid
age
group
youngest
age
group
avail
nhane
dna
bank
case
stratifi
presenc
absenc
chronic
medic
condit
patient
known
increas
risk
influenzaassoci
complic
includ
moder
sever
development
delay
hemoglobinopathi
immunosuppress
disord
asthma
reactiv
airway
diseas
diabet
mellitu
histori
febril
seizur
seizur
disord
cystic
fibrosi
cardiac
renal
chronic
pulmonari
metabol
neuromuscular
disord
casepati
without
chronic
medic
condit
classifi
previous
healthi
casepati
admit
inpati
ward
intens
care
unit
classifi
hospit
length
ill
defin
durat
time
report
date
ill
onset
death
casepati
length
ill
day
classifi
sudden
death
bacteri
coinfect
defin
least
posit
cultur
bacteri
pathogen
normal
steril
site
eg
blood
cerebrospin
fluid
minor
allel
frequenc
group
compar
test
binomi
proport
null
hypothesi
differ
minor
allel
frequenc
case
refer
sampl
priori
group
examin
subgroup
analys
includ
previous
healthi
casepati
casepati
year
old
casepati
invas
bacteri
coinfect
casepati
sudden
death
differ
length
ill
evalu
kaplanmei
estim
differ
test
logrank
statist
test
signific
base
test
test
departur
hardyweinberg
equilibrium
refer
sampl
publish
analys
conduct
sa
version
sa
institut
cari
nc
usa
studi
exempt
institut
review
board
review
approv
human
subject
research
data
obtain
deceas
casepati
refer
sampl
data
use
deidentifi
aggreg
manner
case
fatal
influenza
children
young
adult
report
cdc
influenza
season
case
avail
autopsi
specimen
suffici
dna
genotyp
casepati
characterist
summar
tabl
genotyp
casepati
median
age
year
rang
year
femal
sixtyon
percent
casepati
white
black
seventyfour
percent
case
occur
influenza
season
eightyon
casepati
infect
influenza
influenza
b
signific
differ
distribut
influenza
type
season
case
nation
pattern
type
found
us
viral
surveil
system
data
shown
compar
casepati
genotyp
casepati
dna
avail
genotyp
slightli
older
median
age
year
vs
year
p
less
like
preexist
medic
condit
vs
p
less
like
vaccin
influenza
season
death
vs
p
casepati
genotyp
like
experienc
sudden
death
vs
p
die
reach
medic
care
vs
p
surpris
casepati
sudden
death
like
undergon
autopsi
henc
tissu
avail
dna
extract
genotyp
casepati
less
like
pneumonia
evid
chest
radiograph
vs
p
equal
like
invas
bacteri
coinfect
vs
signific
differ
characterist
difficult
interpret
genotyp
casepati
less
like
receiv
medic
care
ill
presum
greater
frequenc
sudden
death
genotyp
minor
allel
frequenc
among
casepati
summar
tabl
minor
allel
frequenc
compar
casepati
nhane
refer
sampl
shown
figur
statist
signific
differ
observ
minor
allel
frequenc
genotyp
preval
casepati
nhane
refer
sampl
tnf
variant
casepati
examin
togeth
black
white
racial
group
examin
separ
length
ill
shorter
among
casepati
tnf
ag
genotyp
among
gg
genotyp
median
length
ill
day
vs
day
p
casepati
aa
genotyp
estim
odd
ratio
sudden
death
casepati
ag
genotyp
compar
casepati
gg
genotyp
p
fisher
exact
test
signific
associ
found
tnf
variant
examin
bacteri
coinfect
statist
signific
differ
observ
minor
allel
frequenc
snp
examin
figur
preval
pool
genotyp
figur
casepati
nhane
refer
sampl
casepati
examin
togeth
black
white
racial
group
examin
separ
subgroup
analysi
minor
allel
frequenc
significantli
less
common
among
casepati
year
old
refer
sampl
vs
p
among
low
produc
mbl
observ
estim
odd
ratio
confid
interv
ci
invas
methicillinresist
staphylococcu
aureu
mrsa
coinfect
compar
casepati
high
intermedi
mbl
product
accord
genotyp
p
fisher
exact
test
tabl
lowproduc
genotyp
also
associ
approxim
increas
risk
bacteri
coinfect
gener
aureu
infect
overal
associ
reach
statist
signific
characterist
casepati
invas
mrsa
coinfect
shown
tabl
found
signific
differ
allel
frequenc
genotyp
preval
variant
tnf
gene
fatal
influenza
case
patient
year
old
nation
repres
refer
sampl
howev
among
casepati
die
die
childhood
variant
respons
low
product
mbl
associ
mrsa
coinfect
observ
view
cautious
hypothesi
explor
given
small
number
casepati
mrsa
studi
n
find
consist
result
previou
studi
found
associ
mbl
insuffici
defin
genotyp
respiratori
infect
children
sever
fatal
sepsi
system
inflammatori
respons
syndrom
children
tnf
potent
proinflammatori
cytokin
produc
earli
innat
immun
respons
infect
promot
wide
rang
immunolog
respons
excess
system
tnf
respons
mani
symptom
clinic
infect
may
lead
fatal
complic
studi
demonstr
signific
genet
contribut
circul
tnf
level
varianc
tnf
level
genet
determin
studi
snp
posit
allel
associ
greater
tnf
product
suscept
sever
numer
infecti
diseas
carriag
allel
posit
also
associ
varieti
diseas
mbl
anoth
key
compon
innat
immun
system
solubl
protein
collectin
famili
bind
microbi
surfac
promot
phagoopson
directli
indirectli
activ
lectin
complement
pathway
low
serum
mbl
level
common
associ
increas
risk
varieti
infect
autoimmun
diseas
includ
acut
respiratori
infect
young
children
mbl
level
strongli
influenc
genet
factor
variat
mbl
level
explain
small
number
polymorph
gene
variant
protein
unstabl
lower
oligomer
form
decreas
affin
microbi
ligand
complementactiv
abil
variant
produc
significantli
reduc
serum
mbl
level
mbl
shown
strongli
bind
aureu
suscept
fatal
aureu
infect
due
mbl
defici
convincingli
demonstr
murin
model
phase
clinic
trial
mbl
replac
therapi
indic
therapi
well
toler
effect
improv
mbl
defici
healthi
person
report
mbl
replac
therapi
administ
sever
ill
person
patient
aureu
sepsi
suggest
therapi
improv
clinic
condit
although
result
studi
mix
case
clinic
improv
temporari
clinic
implic
mbl
replac
therapi
influenza
treatment
prevent
unknown
among
person
fatal
case
observ
increas
risk
sudden
death
carrier
variant
allel
tnf
unawar
previou
literatur
report
similar
associ
obviou
biolog
mechan
explain
find
tnf
variant
linkag
disequilibrium
tnf
variant
http
pgagswashingtonedu
includ
tnf
associ
increas
tnf
serum
level
therefor
possibl
observ
associ
may
due
linkag
disequilibrium
unmeasur
polymorph
causal
variant
exhaust
analysi
tnf
variant
worthi
futur
studi
strength
studi
use
cohort
casepati
particularli
wellsuit
investig
potenti
host
genet
risk
casepati
die
activ
influenza
infect
yet
predominantli
children
young
adult
without
sever
preexist
medic
condit
group
factor
associ
sever
influenza
less
like
obscur
possibl
genet
associ
addit
strength
access
postmortem
lung
tissu
immunohistochemistri
andor
rtpcr
confirm
influenza
infect
recogn
studi
sever
limit
although
studi
cohort
knowledg
largest
sampl
fatal
influenza
case
children
young
adult
analysi
limit
statist
power
detect
associ
small
sampl
size
especi
examin
subsampl
access
limit
inform
racial
ethnic
background
casepati
clinic
data
obtain
primarili
us
surveil
system
valid
medic
chart
review
although
abl
infer
truncat
haplotyp
haplotyp
inform
tnf
unavail
despit
shortcom
possibl
specif
variant
gene
known
influenc
serum
mbl
level
appear
associ
sever
bacteri
coinfect
intrigu
find
deserv
addit
studi
especi
given
preval
coinfect
among
casepati
die
pandem
viru
infect
observ
children
coinfect
influenza
aureu
may
higher
casefat
rate
observ
stronger
relationship
lowproduc
mbl
genotyp
mrsa
infect
genotyp
aureu
infect
gener
puzzl
unawar
obviou
physiolog
explan
low
mbl
would
predispos
strongli
infect
methicillinresist
versu
methicillinsensit
aureu
one
possibl
mrsa
marker
strain
characterist
exampl
associ
could
aris
mrsa
infect
predominantli
strain
aureu
infect
predominantli
strain
unfortun
data
aureu
genet
strain
type
also
found
fatal
influenza
case
patient
mrsa
coinfect
lowproduc
mbl
genotyp
patient
reportedli
also
asthma
wellestablish
asthma
increas
risk
seriou
complic
influenza
although
know
evid
suggest
lowproduc
mbl
genotyp
associ
increas
risk
asthma
find
may
worth
explor
futur
studi
find
suggest
sever
opportun
addit
influenzarel
research
obviou
next
step
examin
function
variant
gene
conjunct
gene
express
function
assay
larger
group
sever
ill
influenza
casepati
suffici
detail
clinic
data
defin
import
phenotyp
eg
mrsa
coinfect
interest
associ
studi
rare
variant
avail
new
sequenc
technolog
dramat
decreas
cost
sequenc
access
refer
human
sequenc
data
suggest
investig
rare
variant
candid
gene
includ
tnf
function
effect
may
promis
avenu
research
largescal
genotyp
sampl
casepati
look
common
variant
use
method
genomewid
associ
studi
may
possibl
network
collabor
capabl
pool
suffici
number
casepati
develop
recent
initi
genomebas
research
popul
health
intern
network
aim
encourag
network
given
rapid
acceler
laboratori
technolog
enhanc
bioinformat
method
capac
trend
toward
collabor
research
within
larg
consortia
explor
role
host
genom
factor
seriou
ill
associ
influenza
viral
pathogen
increasingli
feasibl
believ
host
genom
promis
area
futur
research
regard
risk
sever
complic
acut
infecti
diseas
includ
influenza
